Sullivan & Cromwell advised Merck KGaA, Darmstadt, Germany, while Goodwin Procter advised SpringWorks Therapeutics on the transaction. Skadden advised Centerview Partners and Goldman Sachs & Co....
Merck’s $3.9 Billion Acquisition of SpringWorks Therapeutics
Bristol Myers Squibb’s $286 Million Acquisition of 2seventy bio
Covington & Burling advised Bristol Myers Squibb on the deal, and Goodwin Procter advised 2seventy bio. Bristol Myers Squibb (NYSE: BMY) (“BMS”) announced its merger agreement...
Collegium Pharmaceutical’s $525 Million Acquisition Of Ironshore Therapeutics
Lazard is acting as the exclusive financial advisor to Collegium. Hogan Lovells is serving as M&A legal counsel to Collegium. Goodwin Procter LLP is serving as...
AVROBIO’s Merger with Tectonic Therapeutic
Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
Pathos AI’s Acquisition of Rain Oncology
Leerink Partners is acting as exclusive financial advisor and Gibson, Dunn & Crutcher LLP is acting as legal counsel to Rain. Goodwin Procter LLP is acting...
Acino’s Acquisition of M8 Pharmaceuticals
Banco J.P. Morgan S.A. is acting as exclusive financial advisor, Goodwin LLP as exclusive legal advisor, and PWC as exclusive accounting and tax advisor to Acino....
Eli Lilly’s $1.925 Billion Acquisition of Versanis Bio
Kirkland & Ellis acted as legal counsel to Eli Lilly, while for Versanis, Goodwin Procter acted as legal counsel and Cooley advised as to patent matters....
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
Regeneron Pharmaceuticals’ Acquisition of Checkmate Pharmaceuticals
Wachtell, Lipton, Rosen & Katz advised Regeneron on the deal, while Goodwin represented Checkmate Pharmaceuticals. Fried Frank acted as counsel to Centerview Partners, financial advisor to...
Caris Life Sciences’ $830 Million Growth Equity Round
Shearman & Sterling represented Caris Life Sciences Inc. in the transaction. Caris Life Sciences Inc. executed an $830 million growth equity round. As a result of...
AMD’s $35 Billion Acquisition of Xilinx
Latham & Watkins LLP and LNT & Partners served as ADM legal advisors., while Skadden, Arps, Slate, Meagher & Flom LLP served as Xilinx legal counsel...